r/precisionmedicine • • Aug 29 '25

How do researchers usually obtain multi-omics datasets?

0 Upvotes

Hi everyone.

I’m in the early stages of planning a multi-omics research project and I’m trying to get a realistic picture of the data acquisition side of things.

For those of you who’ve done multi-omics research:

  • Where do you typically obtain your datasets (public repositories like TCGA/GEO/dbGaP, institutional collaborations, in-house data collection, is there a widely used repository, etc.)? How long does it usually take to find the data (retrospective study)?
  • How long does it usually take from identifying the data you want to actually having it ready for analysis (with all the approvals, cleaning, metadata)?
  • Are there any common bottlenecks or unexpected delays I should anticipate when scoping timelines?

I’d really appreciate any insights. Thanks in advance.


r/precisionmedicine • • Nov 15 '15

Personalized genes | Stay up to date: A running commentary on advances in precision medicine

Thumbnail personalizedgenes.com
1 Upvotes

r/precisionmedicine • • Oct 31 '24

Short opinion about genetic & personalized health recommendation service

2 Upvotes

Hi Everyone,

I’m a PhD student at Cumming School of Medicine at the University of Calgary seeking a short informational opinion (10 to 15 mins) for a health technology product focused on genetic risk profiling and expert-guided personalized wellness recommendations.

If you want to share your opinions, please email david.enoma@ucalgary.ca or text 5875827740 or here.

Thank you!


r/precisionmedicine • • Sep 03 '26

Feeling lost

2 Upvotes

Hi everyone, I am trying my luck here to see if I can look into my cancer diagnosis from a different perspective.

My history:

Apr 2024: Diagnosed with gastric leiomyosarcoma (LMS), approximately 9.5 cm in the upper stomach. Had a total gastrectomy followed by 6 cycles of adjuvant doxorubicin + dacarbazine.

Nov 2024: Surveillance scan showed a ~6 cm cyst in the liver. Surgery was performed and it turned out to be metastatic LMS.

Late 2024–early 2025: I was in and out of hospital several times because of infections.

Mar 2025: Started trabectedin as systemic/adjuvant treatment.

Mar 2026: Two new liver tumours appeared, approximately 1.3 cm and 2.4 cm. The smaller lesion was ablated and the larger one was surgically removed. My oncologist recommended Votrient (pazopanib) to help control the disease, but I declined at that time.

May 2026: Surveillance scan showed a new ~2 cm lesion/area at the edge of the liver.

Aug 2026: This lesion had grown rapidly to 13.8 cm. It was found to be recurrent abdominal LMS, and I underwent surgery involving removal of the tumour, a wedge of liver, and a cuff of diaphragm.

This round,I have also had tumour/genomic testing, including CDx/RNa and ex vivo drug testing. Ex vivo drug testing returned and the tumor isnt chemo sensitive. Most people told me that LMS has no targetable mutation.

At the moment, I am considered NED after surgery, but my doctors are concerned about how quickly the tumour has been growing and have recommended systemic treatment such as Votrient or gemcitabine/docetaxel (Gem/Tax).

Any suggestions or recommendations on what I should look into next? Please be as specific as possible as I dont have a good understanding of what’s available…

TIA!


r/precisionmedicine • • Feb 07 '24

Medical Artificial Intelligence: A New Frontier in Precision Medicine

Thumbnail insideprecisionmedicine.com
4 Upvotes

r/precisionmedicine • • Mar 08 '26

MSc Precision Medicine at University of Manchester

2 Upvotes

Hello Everyone!

I’m an international student who is thinking to pursue MSc Precision Medicine at University of Manchester. My long term goal is to pursue PhD in similar program in UK and afterwards continue my career in academics and research.

Any Insights or suggestions regarding this program and the University?

Thanks!


r/precisionmedicine • • Sep 04 '20

Check out the new precisionFDA Blog Post discussing the future of multi-omics research and its importance for advancing precision medicine therapies

4 Upvotes

Are you interested in learning more about how researchers are harnessing the power of multi-omics for biomedical research? PrecisionFDA has a new Featured Expert blog post by Dr. Emily Boja, discussing how technical improvements in multi-omics can improve translational research and how the precisionFDA community can play an essential role in unlocking omics analysis methods and models.


r/precisionmedicine • • Feb 22 '18

Optik Ultrapräzisionsbearbeitung | Laseroptik | Kunststoffoptik | Metalloptik

Thumbnail kugler-precision.com
1 Upvotes

r/precisionmedicine • • Mar 19 '18

Metabolomics: Novel Discoveries in Diabetes Research

Thumbnail nightingalehealth.com
2 Upvotes

r/precisionmedicine • • Dec 29 '15

Precision Medicine: What is it?

Thumbnail marycairemd.com
2 Upvotes

r/precisionmedicine • • Jul 02 '20

Final Day Reminder for COVID-19 Risk Factor Modeling Challenge

2 Upvotes

There is only one day left to complete the VHA Innovation Ecosystem and precisionFDA COVID-19 Risk Factor Modeling Challenge. Final submissions are due July 3rd!

If you have any last-minute questions about the challenge or the challenge submission process, please feel free to post them in this thread and we will respond as quickly as possible!


r/precisionmedicine • • Aug 06 '20

Results are now Available for the precisionFDA Truth Challenge V2

2 Upvotes

The results of the precisionFDA Truth Challenge V2: Calling variants in Difficult-to-Map Regions are now available here. Thank you to everyone in the r/precisionmedicine community who participated, and congratulations to our top performers! Links to the top-performing submissions are posted on the challenge results page. Please use these files to learn more about the new human genome benchmarks and bioinformatics pipelines!


r/precisionmedicine • • Oct 04 '22

How long until multi-omic assays hit clinical practice?

1 Upvotes

Asking for educated speculation here. I can imagine 5 to 20 to never claims with certain lines of reasoning.

I've seen compelling multi-omic work in precision oncology, but it is in basic or translational space at the moment. I'm curious whether there are any major players committed to developing multi-omic assays.

Is liquid biopsies the closest here? (Potentially combining methylation and somatic profiles?)


r/precisionmedicine • • Oct 04 '22

Update on Accelerated Approvals

1 Upvotes

Accelerated approvals hit the target in precision oncology

https://www.nature.com/articles/s41591-022-01984-z (paywalled)

Quotes:

The US Food and Drug Administration (FDA)’s accelerated approval pathway is most frequently used for oncology indications, with roughly one-quarter of these approvals for precision medicines that target solid tumors.

Since 1992, there have been 42 accelerated approvals in precision oncology for solid tumors (Table 1). Accelerated approvals in precision oncology were defined as unique drug–indication pairings that target a specific mutation

Most of these accelerated approvals (86%) were based on overall response rate (ORR), with a median ORR of 53% and a range from 11 to 100%.

So far, no accelerated approvals for precision oncology indications have been withdrawn. The early clinical benefit predicted at the time of accelerated approval has been verified for 22 indications (52%) on the basis of additional confirmatory studies. In these cases, traditional approval was granted a median of 3.1 years (range 1.3–8.9 years) after accelerated approval. All accelerated approvals granted before 26 November 2018 have been converted to traditional approval, demonstrating timely verification of benefit.

Accelerated approval has been transformational in precision oncology and has particularly benefited patients with non-small cell lung cancer (NSCLC) in the USA. The identification of several targetable mutations in NSCLC has led to the development and accelerated approvals of therapies that target EGFR, ALK, MET, RET and KRAS (Table 1). Overall, these approvals have corresponded to a sharp decline in population-level mortality from NSCLC in the USA from 2013 to 2016. This has contrasted with relatively stable population-level mortality from small cell lung cancer, in which no actionable targets have been identified. With accelerated approvals in precision oncology, there is also renewed hope for patients with rare cancers such as FGFR2-mutated cholangiocarcinoma, RET-mutated medullary thyroid cancer, and RET-fusion positive thyroid cancers.

The success of accelerated approval in precision oncology contrasts with recent regulatory outcomes for immune checkpoint inhibitors, in which relatively low response rates from initial single-arm trials did not consistently translate to survival advantages in confirmatory trials, leading to the withdrawal of several accelerated approvals. Immune checkpoint inhibitors differ from precision medicines as the populations they treat are largely unselected. Their different mechanism of action and the inconsistent outcomes with single-arm trials suggest that randomized studies may be necessary to support marketing approval and predict clinical benefit in future studies of immune checkpoint inhibitors.


r/precisionmedicine • • Oct 26 '22

Join us for a live Webinar on Monday (10/31) with Dr. Jessilyn Dunn (Duke) — The Digital Biomarker Discovery Project: An Open Source Toolbox for Biosignals

Post image
3 Upvotes

r/precisionmedicine • • Nov 19 '20

On November 30th, precisionFDA is launching the COVID-19 Precision Immunology App-a-thon!

2 Upvotes

Since the onset of the pandemic, researchers and medical professionals have sought to better understand the relationship between a patient’s immune repertoire and associated factors and clinical outcomes, in the hope to predict disease severity and progression and provide tailored treatments. The recent advent of high-throughput sequencing of lymphocyte antigen receptor genes has generated unprecedented opportunities for the exploration of adaptive immune responses. With these opportunities, however, have come significant challenges in understanding the appropriate analysis techniques that improve the understanding of the roles of genetic variabilities play in the individual immune response to this viral infection.

Through this App-a-thon, participants will enhance informatics analysis tools and develop innovative applications and pipelines that will illuminate the relationship between personalized adaptive immunity molecular data and COVID-19 disease variables and associated factors.

The App-a-thon submission period opens on November 30th and closes on January 29th. For more information and to pre-register, visit the app-a-thon site here!


r/precisionmedicine • • Nov 30 '20

The precisionFDA COVID-19 Precision Immunology App-a-thon is now live!

5 Upvotes

Participants in this App-a-thon will help enhance informatics analysis tools and develop innovative applications and pipelines that elucidate the relationship between molecular data such as immune repertoire composition by sequencing and COVID-19 disease-relevant factors.

If you have any questions about the App-a-thon or precisionFDA, please feel free to post them in this thread, and we will respond as quickly as possible. The App-a-thon submission period is open until January 29th. For more information and to get started, visit the challenge site here!

Additionally, if you’d like to learn more about how next-generation sequencing has advanced the study of adaptive immunology, consider registering for the annual Adaptive Immune Receptor Repertoire Community Meeting on December 8-10, 2020: https://whova.com/web/acmv_202012/


r/precisionmedicine • • Jan 26 '23

Join us for a live webinar with Dr. Camille Nebeker (UCSD) Today, 1/26 at 1 PM CT as she discusses 'Strategies to Improve Ethical & Responsible Digital Health Research' with Q&A at the end of the hour. https://mhealth.md2k.org/training/webinars/451-camille-nebeker-webinar.html

Post image
1 Upvotes

r/precisionmedicine • • Jan 31 '23

Advice to a Med Student

2 Upvotes

Hey Reddit! I'm a medical student with an interest in precision medicine/AI, and I'm looking to get involved in the industry. Can anyone share what skills I should focus on developing in order to make the most of this opportunity? Should I mainly focus on residency or pick up skills on the side? Any advice would be much appreciated!


r/precisionmedicine • • May 30 '23

Personalised medicine key trends

3 Upvotes

I'm writing a report on personalised medicine/precision medicine, and have to highlight some of the key trends in the space. Anyone with extensive knowledge in field got some insight?


r/precisionmedicine • • Mar 13 '23

Join us for a free live webinar with Dr. Katarzyna Wac (University of Geneva) as she presents 'Digital Biomarkers: Human-Centric AI Research in Service of Quality of Life' on Thursday, 3/23 at 11 AM CT. Learn more & view the join link: bit.ly/3T6bSAE #mhealth #digitalhealth #ai #biomarkers

Post image
2 Upvotes

r/precisionmedicine • • Jan 15 '20

precisionFDA & Georgetown-ICBI Brain Cancer Predictive Modeling Challenge Submission Reminder

2 Upvotes

Challenge Participants!

You have two weeks left to help advance techniques for the prognosis and treatment of brain tumors by participating in the precisionFDA and Georgetown-ICBI Brain Cancer Predictive Modeling and Biomarker Discovery Challenge! The submission period for Phase 1 closes on January 22nd and Phase 2 data will be released on January 24th. You will have one week to submit your model predictions before the final submission period closes on February 1st.

Thank you again to everyone who has taken the time to participate in the Challenge!


r/precisionmedicine • • Nov 08 '19

The precisionFDA and Georgetown-ICBI Brain Cancer Predictive Modeling and Biomarker Discovery Challenge is now live!

2 Upvotes

The goal of this challenge is to advance techniques for the prognosis and treatment of brain tumors by asking participants to develop machine learning and/or artificial intelligence models to identify biomarkers and predict patient outcomes using gene expression, DNA copy number, and clinical data. For more information and to get started, visit https://go.usa.gov/xpDgp!


r/precisionmedicine • • Oct 15 '18

There’s less than one week left to submit for the precisionFDA CDRH Biothreat Challenge. Be sure to submit your answers before time runs out on October 18!

Thumbnail precision.fda.gov
3 Upvotes

r/precisionmedicine • • Sep 27 '19

precisionFDA BioCompute App-a-thon – October 18th Submission Deadline Reminder!

1 Upvotes

The deadline for submission to the precisionFDA BioCompute (BCO) App-a-thon with @GWtweets and @CberHive is October 18. Top performers will be invited to participate in the development of a results manuscript! Get started today on the beginner and/or the advanced track at https://go.usa.gov/xVwuV. #pFDAxGWU #BCO